[HTML][HTML] Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms
AD Proal, MB VanElzakker - Frontiers in microbiology, 2021 - frontiersin.org
The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients …
a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients …
[HTML][HTML] Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms
The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
COVID-19 and autoimmune diseases
Y Liu, AH Sawalha, Q Lu - Current opinion in rheumatology, 2021 - journals.lww.com
We present a review of the association between COVID-19 and autoimmune diseases,
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …
[HTML][HTML] Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
ZA Sherif, CR Gomez, TJ Connors, TJ Henrich… - Elife, 2023 - elifesciences.org
COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …
[HTML][HTML] Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
AC Medeiros-Ribeiro, NE Aikawa, CGS Saad… - Nature medicine, 2021 - nature.com
CoronaVac, an inactivated SARS-CoV-2 vaccine, has been approved for emergency use in
several countries. However, its immunogenicity in immunocompromised individuals has not …
several countries. However, its immunogenicity in immunocompromised individuals has not …
SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis
Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across
the globe at unprecedented speed and is showing no signs of slowing down. The outbreak …
the globe at unprecedented speed and is showing no signs of slowing down. The outbreak …
Infectious Diseases Society of America guidelines on the diagnosis of coronavirus disease 2019
IDSA Disclaimer As of the time of this publication, updates have been made to IDSA's
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …
vaccines. Our prospective observational multicenter study aimed to evaluate the …
[HTML][HTML] Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in …
CI Vardavas, AG Mathioudakis… - European …, 2022 - Eur Respiratory Soc
Background As mortality from coronavirus disease 2019 (COVID-19) is strongly age-
dependent, we aimed to identify population subgroups at an elevated risk for adverse …
dependent, we aimed to identify population subgroups at an elevated risk for adverse …